- Home
- MCVT vs CARM Comparison
MCVT vs CARM Comparison
Compare MCVT & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- CARM
- Stock Information
- Founded
- MCVT 2007
- CARM 2016
- Country
- MCVT United States
- CARM United States
- Employees
- MCVT N/A
- CARM N/A
- Industry
- MCVT Finance Companies
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- MCVT Finance
- CARM Health Care
- Exchange
- MCVT Nasdaq
- CARM Nasdaq
- Market Cap
- MCVT 9.3M
- CARM 8.4M
- IPO Year
- MCVT N/A
- CARM N/A
- Fundamental
- Price
- MCVT $1.83
- CARM $0.39
- Analyst Decision
- MCVT
- CARM Hold
- Analyst Count
- MCVT 0
- CARM 5
- Target Price
- MCVT N/A
- CARM $0.90
- AVG Volume (30 Days)
- MCVT 16.1K
- CARM 42.1M
- Earning Date
- MCVT 08-13-2025
- CARM 08-07-2025
- Dividend Yield
- MCVT N/A
- CARM N/A
- EPS Growth
- MCVT N/A
- CARM N/A
- EPS
- MCVT 0.19
- CARM N/A
- Revenue
- MCVT $3,246,479.00
- CARM $19,964,000.00
- Revenue This Year
- MCVT N/A
- CARM N/A
- Revenue Next Year
- MCVT N/A
- CARM N/A
- P/E Ratio
- MCVT $9.65
- CARM N/A
- Revenue Growth
- MCVT N/A
- CARM 32.45
- 52 Week Low
- MCVT $1.13
- CARM $0.14
- 52 Week High
- MCVT $3.88
- CARM $1.70
- Technical
- Relative Strength Index (RSI)
- MCVT 50.24
- CARM 52.02
- Support Level
- MCVT $1.77
- CARM $0.41
- Resistance Level
- MCVT $1.91
- CARM $0.56
- Average True Range (ATR)
- MCVT 0.08
- CARM 0.13
- MACD
- MCVT -0.01
- CARM -0.01
- Stochastic Oscillator
- MCVT 36.11
- CARM 20.33
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.